Evidence map›Paper›PMID 10449442›Full record

ArticleThe Journal of clinical investigation1999

Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD.

S Srivastava, M N Weitzmann, S Cenci, F P Ross, S Adler, R Pacifici

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 255 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Maternal C-reactive protein and in vitro fertilization (IVF) cycles.Journal of assisted reproduction and genetics · 2020
    Review
  10. Article
  11. Article
  12. Characterizing how probioticBone reports · 2019
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

S SrivastavaDivision of Bone and Mineral Diseases, Department of Pathology, Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, Missouri 63110, USA.
M N Weitzmann
S Cenci
F P Ross
S Adler
R Pacifici
Barnes-Jewish Hospital · US

Funding

IL-1 RECEPTOR ANTA IN OVARRIECTOMY INDUCED BONE LOSSR01AR041412 · NIAMS · JEWISH HOSPITAL OF SAINT LOUIS · PI PACIFICI, ROBERTO · 1991 to 2004
$1.4M
ESTROGEN REGULATION OF TNF GENE EXPRESSIONR03AR045829 · NIAMS · UNIVERSITY OF CINCINNATI · PI SRIVASTAVA, SUNIL K · 1998 to 2000
$77k
NIAMS NIH HHS AR-41412NIAMS NIH HHS AR-45829NIAMS NIH HHS R01 AR041412
6 · The paper itself

Abstract

Central to the bone-sparing effect of estrogen (E(2)) is its ability to block the monocytic production of the osteoclastogenic cytokine TNF-alpha (TNF). However, the mechanism by which E(2) downregulates TNF production is presently unknown. Transient transfection studies in HeLa cells, an E(2) receptor-negative line, suggest that E(2) inhibits TNF gene expression through an effect mediated by estrogen receptor beta (ERbeta). We also report that in RAW 264.7 cells, an E(2) receptor-positive murine monocytic line, E(2) downregulates cytokine-induced TNF gene expression by decreasing the activity of the Jun NH(2)-terminal kinase (JNK). The resulting diminished phosphorylation of c-Jun and JunD at their NH(2)-termini decreases the ability of these nuclear proteins to autostimulate the expression of the c-Jun and JunD genes, thus leading to lower production of c-Jun and JunD. The consequent decrease in the nuclear levels of c-Jun and JunD leads to diminished binding of c-Jun/c-Fos and JunD/c-Fos heterodimers to the AP-1 consensus sequence in the TNF promoter and, thus, to decreased transactivation of the TNF gene.

Indexed as

Mitogen-Activated Protein KinasesBase SequenceCalcium-Calmodulin-Dependent Protein KinasesCell LineDNA PrimersDown-RegulationEstradiolEstrogen Receptor alphaEstrogen Receptor betaHeLa CellsHumansInterleukin-1JNK Mitogen-Activated Protein KinasesMonocytesPhosphorylationPromoter Regions, GeneticCalcium-Calmodulin-Dependent Protein KinasesDNA PrimersEstradiolEstrogen Receptor alphaEstrogen Receptor betaInterleukin-1JNK Mitogen-Activated Protein KinasesMitogen-Activated Protein KinasesProto-Oncogene Proteins c-junReceptors, EstrogenRNA, MessengerTranscription Factor AP-1Tumor Necrosis Factor-alpha

Identifiers

PMID10449442
PMCPMC481048
OpenAlexW2157009361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.